Micropharma files patents for probiotic technologies
date:Sep 21, 2012
Micropharma, which is involved in the development of probiotics, has announced that it has filed a number of patents for its probiotic technologies.

Probiotics are bacteria that offer a health benefit to the host. They are being studied to determine if they may have a more significant role in helping to maintain and improve health and wellness through the gut.

Micropharma president and chief executive officer Ryan Jones said that Micropharma has invested significantly over the past several yea
1/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/15 03:45